Stock Market Reviews

Read and share opinions on TIVC (Tivic Health Systems, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Tivic Reports Third Quarter 2025 Financial Results
  Nov 14, 2025
• Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
  Nov 13, 2025
• Tivic Expands Intellectual Property Portfolio
  Nov 10, 2025
• Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
  Nov 6, 2025
• Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
  Oct 22, 2025
• Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference
  Sep 22, 2025
• Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing
  Sep 10, 2025
• Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
  Aug 20, 2025
• Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
  Aug 15, 2025
• Tivic Reports Second Quarter 2025 Financial Results
  Aug 14, 2025
• Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast
  Aug 7, 2025
• Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO
  Jul 8, 2025
• Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device
  Jun 25, 2025
• Tivic Health Announces 2025 Annual Meeting of Stockholders
  Jun 24, 2025
• Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation
  May 15, 2025
• Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission
  May 14, 2025